Related Experiment Video
Updated: Aug 10, 2026

Use of In vivo Imaging to Monitor the Progression of Experimental Mouse Cytomegalovirus Infection in Neonates
Published on: July 6, 2013
Acquisition of cytomegalovirus infection by premature neonates
C R de Cates1, J Gray, N R Roberton
1Neonatal Unit, Rosie Maternity Hospital, Cambridge, U.K.
Insights
Premature infants are at risk for cytomegalovirus (CMV) infection. Transfusing with CMV antibody-negative blood significantly reduces infection risk in these vulnerable newborns.
Area of Science:
- Neonatal Medicine
- Infectious Diseases
- Pediatric Hematology
Background:
- Cytomegalovirus (CMV) poses a significant risk to premature infants, particularly those born at 32 weeks gestation or less.
- Understanding transmission routes and risk factors for acquired CMV infection in neonates is crucial for prevention strategies.
Purpose of the Study:
- To evaluate the risk of premature infants acquiring cytomegalovirus (CMV) infection.
- To determine the impact of blood transfusions on CMV acquisition in this high-risk population.
Main Methods:
- Prospective study of infants ≤ 32 weeks gestation admitted to a neonatal unit.
- Infants assessed at birth for congenital CMV infection and followed to 1 month post-term.
- CMV infection acquisition analyzed based on maternal CMV antibody status and infant blood transfusion history.
Main Results:
- 12.2% (16/131) of infants acquired CMV infection.
- CMV acquisition was significantly higher in transfused infants: 9.23% (6/65) for those born to CMV-negative mothers and 26.47% (9/34) for those born to CMV-positive mothers.
- The relative risk of CMV acquisition associated with blood transfusion was 3.7.
Conclusions:
- Blood transfusions are a significant risk factor for acquired CMV infection in premature infants.
- All premature infants requiring blood transfusions should receive CMV antibody-negative blood, irrespective of maternal CMV immune status.
- Implementing CMV-screened blood transfusions can reduce infection rates in vulnerable neonatal populations.
Abstract:
In order to evaluate the risk of premature infants acquiring cytomegalovirus (CMV) infection, a prospective study was made of infants of 32 weeks gestation or less admitted to a neonatal unit. Infants were assessed at birth to exclude congenital CMV infection and followed to the age of 1 month post-term. A total of 16/131 (12.2%) infants acquired CMV infection; 6 of CMV antibody-negative and 10 of CMV antibody-positive mothers. Six of 65 (9.23%) infants of CMV antibody-negative mothers who had been transfused with blood acquired CMV infection compared with 0 of 18 infants of CMV antibody-negative mothers, and who had not been transfused with blood. Acquired CMV infection was also more common in infants of CMV antibody-positive mothers and who had been transfused with blood, i.e. 9 of 34 (26.47%) compared with 1 of 14 (7.14%). The relative risk was 3.7 (95% confidence interval 1.53-5.87). This study suggests that all premature infants requiring blood transfusion should be transfused with CMV antibody-negative blood regardless of the CMV immune status of their mothers.
More Related Videos
08:08qPCR Is a Sensitive and Rapid Method for Detection of Cytomegaloviral DNA in Formalin-fixed, Paraffin-embedded Biopsy Tissue
Published on: July 9, 2014
05:51Intracerebroventricular and Intravascular Injection of Viral Particles and Fluorescent Microbeads into the Neonatal Brain
Published on: July 24, 2016
Related Concept Videos
Development of Immunocompetence
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Immunodeficiency Diseases
There are three main causes of immunodeficiency disorders...
Poliomyelitis
Cytomegalovirus Disease
Respiratory Syncytial Virus Disease
Cryptococcal Meningitis